Related Experiment Videos
[Tiapridal and alcoholic detoxication (author's transl)]
Acta Psychiatrica Belgica
|March 1, 1980
Summary
Tiapride effectively managed alcohol withdrawal symptoms in 30 patients over 28 days, reducing alcohol craving and psychiatric issues. While generally safe, some patients required additional anti-epileptic or psycho-relaxant medications.
Area of Science:
- Pharmacology
- Neurology
- Addiction Medicine
Context:
- Assessing tiapride's efficacy and safety in outpatient alcohol detoxification.
- Investigating treatment for alcohol-dependent individuals who decline hospitalization or have comorbidities.
Purpose:
- To evaluate tiapride as a treatment option for alcohol withdrawal syndrome in non-hospitalized patients.
- To determine the effectiveness of tiapride in managing psychiatric, neurological, and digestive symptoms associated with alcohol cessation.
Summary:
- A 28-day survey involved 30 alcoholics treated with intramuscular then oral tiapride.
- Significant improvement in withdrawal symptoms, including delirium tremens, was observed within two weeks.
- Most psychiatric, neurological, and digestive disorders resolved, with reduced alcohol craving and no somnolence.
Impact:
- Tiapride shows promise for outpatient alcohol detoxification, reducing withdrawal severity and craving.
- The study highlights the need for potential adjunctive therapies like anti-epileptics and anxiolytics for specific patient needs.
- Tiapride offers a viable option for managing alcohol dependence in ambulatory settings, improving patient outcomes.